London
· Delayed Price · Currency is GBP · Price in USD UnitedHealth Group Statistics
Total Valuation
LON:0R0O has a market cap or net worth of GBP 339.55 billion. The enterprise value is 383.78 billion.
| Market Cap | 339.55B |
| Enterprise Value | 383.78B |
Important Dates
The next estimated earnings date is Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | Dec 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.96% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 917.84M |
Valuation Ratios
The trailing PE ratio is 29.51.
| PE Ratio | 29.51 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 4.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of 23.21.
| EV / Earnings | 33.35 |
| EV / Sales | 1.21 |
| EV / EBITDA | 13.33 |
| EV / EBIT | 15.03 |
| EV / FCF | 23.21 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.75.
| Current Ratio | 0.83 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 2.11 |
| Debt / FCF | 3.71 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is 15.13% and return on invested capital (ROIC) is 11.67%.
| Return on Equity (ROE) | 15.13% |
| Return on Assets (ROA) | 7.06% |
| Return on Invested Capital (ROIC) | 11.67% |
| Return on Capital Employed (ROCE) | 16.60% |
| Revenue Per Employee | 726,659 |
| Profits Per Employee | 26,151 |
| Employee Count | 440,000 |
| Asset Turnover | 1.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.46% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +9.46% |
| 50-Day Moving Average | 568.79 |
| 200-Day Moving Average | 554.34 |
| Relative Strength Index (RSI) | 51.86 |
| Average Volume (20 Days) | 6,464 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, LON:0R0O had revenue of GBP 319.73 billion and earned 11.51 billion in profits. Earnings per share was 12.39.
| Revenue | 319.73B |
| Gross Profit | 71.41B |
| Operating Income | 25.79B |
| Pretax Income | 16.03B |
| Net Income | 11.51B |
| EBITDA | 29.06B |
| EBIT | 25.79B |
| Earnings Per Share (EPS) | 12.39 |
Balance Sheet
The company has 23.25 billion in cash and 61.43 billion in debt, giving a net cash position of -41.21 billion.
| Cash & Cash Equivalents | 23.25B |
| Total Debt | 61.43B |
| Net Cash | -41.21B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 81.95B |
| Book Value Per Share | 84.67 |
| Working Capital | -14.37B |
Cash Flow
In the last 12 months, operating cash flow was 19.33 billion and capital expenditures -2.79 billion, giving a free cash flow of 16.54 billion.
| Operating Cash Flow | 19.33B |
| Capital Expenditures | -2.79B |
| Free Cash Flow | 16.54B |
| FCF Per Share | n/a |
Margins
Gross margin is 22.33%, with operating and profit margins of 8.07% and 3.60%.
| Gross Margin | 22.33% |
| Operating Margin | 8.07% |
| Pretax Margin | 5.01% |
| Profit Margin | 3.60% |
| EBITDA Margin | 9.09% |
| EBIT Margin | 8.07% |
| FCF Margin | 5.17% |
Dividends & Yields
This stock pays an annual dividend of 6.35, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | 6.35 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | 8.88% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 52.29% |
| Buyback Yield | 0.96% |
| Shareholder Yield | 2.07% |
| Earnings Yield | 3.39% |
| FCF Yield | 4.87% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |